Ryan Fecteau, MD, PhD
Radiation Oncologist
My Locations
Part of the Duke Cancer Institute
About Me
I am a radiation oncologist specializing in genitourinary cancers, such as prostate and bladder cancer. I went into radiation oncology because of the ability to use radiation as a tool to cure patients and improve their quality of life. When I meet someone for a consult, I like to gain an understanding of who they are and where they are coming from so that we can come up with a management plan that aligns with their values. I think an important aspect of my job is to educate and ensure that every patient fully understands the treatment options available so that they feel confident about their decision. Outside of work, I like to spend time with my family cooking, traveling, watching Clemson football games, and exploring the Durham food scene.
- Assistant Professor of Radiation Oncology, Radiation Oncology 2025
- Member of the Duke Cancer Institute, Duke Cancer Institute 2024
Call for an Appointment
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
Clinical Focus and Research
-
NRG-GU009 (Prostate Cancer)IRB# PRO00108295 , NCT# NCT04513717
-
NRG-GU008 Prostate CancerIRB# PRO00112257 , NCT# NCT04134260
-
NRG-GU010 Guidance (Prostate Cancer)IRB# PRO00113621 , NCT# NCT05050084
-
NRG-GU012 (Renal Cell Carcinoma)IRB# PRO00117320 , NCT# NCT05327686
- Fecteau, Ryan E., Bridget F. Koontz, Karen E. Hoffman, Susan Halabi, Lauren E. Howard, Monika Anand, Daniel J. George, et al. “Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.” Prostate Cancer Prostatic Dis, February 22, 2024. https://doi.org/10.1038/s41391-024-00811-5.
- Garman, Katherine S., Biswa P. D. Purkayastha, Joyce A. Hogue, Ryan Fecteau, BETRNet CONSORTIUM, Kishore Guda, and Amitabh Chak. “Genetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk.” Gastroenterology 165, no. 6 (December 2023): 1561-1564.e3. https://doi.org/10.1053/j.gastro.2023.08.039.
- Fecteau, Ryan, and W Robert Lee. “The importance of body composition in patients with prostate cancer receiving radiotherapy.” Cancer 129, no. 5 (March 1, 2023): 668–70. https://doi.org/10.1002/cncr.34594.
- Fecteau, R., and A. M. Kieber-Emmons. “Gastrointestinal Malignancies.” In Nutrition, Weight, and Digestive Health: The Clinician’s Desk Reference, 127–37, 2022. https://doi.org/10.1007/978-3-030-94953-2_8.
- Fecteau, R. E., D. Liu, C. E. Barbieri, and H. Nagar. “Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108:S4–S4, 2020.
- Kaylor, K., R. E. Fecteau, R. Pennell, S. L. Chen, O. Balogun, H. R. R. Cardenes, E. B. Golden, and J. Ng. “Initial Outcomes And Treatment-Associated Toxicities Using Stereotactic MRI-Guided Adaptive Radiation Therapy For Pancreatic Cancer Patients Treated At A Single Institution.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108:E617–18, 2020.
- Fecteau, R. E., R. Pennell, R. F. Farjam, and J. Ng. “Initial Dosimetric Outcomes and Treatment Related Toxicities Using Stereotactic MRI-Guided Radiation Therapy (SMART) for Unresectable Pancreatic Cancer at a Single Institution.” In International Journal of Radiation Oncology*Biology*Physics, 105:E235–36. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2008.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- Telix pharmaceuticals